CAMBRIDGE TRUST CO - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 289 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$675,970
-1.8%
11,5000.0%0.03%
-10.3%
Q4 2023$688,390
+57.4%
11,5000.0%0.03%
+45.0%
Q3 2023$437,460
-52.0%
11,500
+15.0%
0.02%
-51.2%
Q2 2023$911,000
+38.1%
10,0000.0%0.04%
+32.3%
Q1 2023$659,600
+127482.2%
10,0000.0%0.03%
+34.8%
Q4 2022$517
-99.9%
10,0000.0%0.02%
-28.1%
Q3 2022$683,000
+51.1%
10,0000.0%0.03%
+60.0%
Q2 2022$452,000
-11.0%
10,0000.0%0.02%
+11.1%
Q1 2022$508,000
+7.4%
10,0000.0%0.02%
+20.0%
Q4 2021$473,00010,0000.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders